First Friday Book Synopsis

MARCH 21, 2012

An entrepreneur and veteran of the computer industry, Frank Moss spent his career bringing innovative technologies to market. Ten years ago he set out to make a broader contribution to the world, leading him to cofound a cancer drug discovery company and then to the MIT Media Lab, where he served as director from 2006 [.].

Entrepreneur 80

Entrepreneur Media Technology Innovation 80

Strategy Driven

NOVEMBER 29, 2016

When it’s time to hire for critical positions within your company, consider the training and certification in military systems offered to service men and women.

Agility 50

Agility Pharmaceuticals Self-aware Crisis Management 50

Harvard Business Review

JUNE 26, 2014

In his 2008 book Patent Failure , Bessen and co-author Michael Meurer argue that after taking the cost of litigation into account, the effect of patenting in all industries except pharmaceuticals and chemicals was to reduce the profitability of innovation rather than to increase it. Innovation Technology'

Innovation 11

Innovation Pharmaceuticals Chemicals Software 11

Harvard Business Review

FEBRUARY 22, 2011

Editor's note: This post is the first in a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. Lack of consensus among players in a complex system is one of the biggest barriers to innovation. It's a classic change management problem.

Health Care 16

Health Care Innovation Pharmaceuticals Consensus 16

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). Because disruptive products were cheaper, more accessible, and built on new technology architectures, they tended to be crummier than the existing highest-end solutions.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Besides Dr Reddy's, several leading Indian firms are pioneering polycentric innovation: Tata Motors. Polycentric innovation won't work in organizations that promote groupthink. Cambridge, U.K. Reliance MediaWorks.

Globalization 10

Globalization Innovation Decentralization Chemicals 10

Harvard Business Review

MARCH 18, 2018

Why the Pharmaceutical Industry Is Booming in Japan. This also includes innovative systems for patient-requested care, promotion of self-medication, cloud-based record availability, and remote monitoring of patients in their homes. Conditional early approval expanded to cover innovative medical devices in July 2017.

Health Care 9

Health Care Industry Pharmaceuticals Content 9

Harvard Business Review

AUGUST 14, 2018

Google, for example, has succeeded in dominating many foreign markets that have radically different political systems and cultures (including Indonesia, Thailand, and Saudi Arabia). imposing technological platforms developed for the U.S. ineffective innovation strategies. 5 Principles for Innovation in Emerging Markets.

Competitive Advantage 13

Competitive Advantage Business Model Technology Marketing 13

Harvard Business Review

OCTOBER 26, 2017

Today when we talk about business “ clusters ,” we’re usually talking about the technology industry in Silicon Valley, the financial sector in London or New York, or automakers in southern Germany. “The medieval guild system was a primitive networking exercise.” Matteo Fagiolino/Getty Images.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

JULY 4, 2017

Tim Cook recently confirmed that Apple is working on ‘autonomous systems.’ The second play is to try to use its technological aptitude to create a vehicle that solves a particular problem. My hope is Apple will do more than just sell more iPhones or use its technological prowess to create a safer way to drive.

Transportation 11

Transportation Sports Pharmaceuticals Health Care 11

Harvard Business Review

OCTOBER 23, 2014

It’s only recently, though, that advances in information technology have made it possible for predictive tools to access and manipulate big data, and to do so continuously — accelerating the generation of insights, and opening up opportunities to anticipate issues with unprecedented precision. They’re also sharing risk.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And that's true in many areas: New devices, pharmaceuticals, and surgical techniques regularly get developed and incorporated into practice.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Strategy Driven

MARCH 18, 2011

Further, they need to limit their focus to, at most, six capabilities, and make those capabilities work together as a mutually reinforcing system that perpetuates competitive advantage. That belief stems from having chosen a differentiated way to play that is supported by a strong system of mutually reinforcing capabilities.

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

FEBRUARY 17, 2011

Venture capitalists are increasingly interested in emerging markets, and in working with local funds based in those markets (despite the fact that reverse innovation in venture capital seems counterintuitive). In effect, the VCs at Nadathur Holdings serve as the executive team for a miniature healthcare innovation ecosystem.

Marketing 15

Marketing Venture Capitalist Biotechnology IPO 15

Harvard Business Review

APRIL 2, 2018

We invest billions of dollars each year in medicines, new technologies, doctors, and hospitals—all with the goal of improving health, arguably our most prized commodity. health care system woefully underperform relative to those made in health care in other countries. rawpixel/Getty Images. Yet, investments in the U.S.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

FEBRUARY 2, 2015

Steel did in an earlier era of manufacturing, Aquion and innovative firms like it are spearheading economic and employment growth across the country. This is the kind of technology—and the type of firm—that will make renewable energy more efficient and more cost-effective. competitiveness and growth in the 21 st century.

Industry 8

Industry McKinsey Engineering Innovation 8

Harvard Business Review

OCTOBER 22, 2013

Innovation starts with new and novel ideas. When we surveyed over 300 global executives between 2008 and 2009, one of the primary concerns they expressed was their inability to compete long term without a solid innovation engine that can grow their top line. Everything, everyone, and every system evolves over time. Find Pivots.

Skills 9

Skills Power Six Sigma Disruptive Innovation 9

Harvard Business Review

APRIL 19, 2016

Carmakers have started using 3D technology to produce parts. Imagine the changes afoot in the pharmaceutical, medical device, automotive, and consumer electronics industries. Innovation, customization, speed, and location are also among the opportunities it offers. trillion in inventories held by U.S.

Supply Chain 8

Supply Chain Execution Analysis Technology 8

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Harvard Business Review

JANUARY 31, 2013

Second, we see a raft of innovations that will alter how products are designed, manufactured and sold — everything from nanotechnologies to 3D printing. Then, manufacturing's most important role is as a driver of innovation, trade, and productivity. Innovations Are Changing The Way We Design Products.

Globalization 10

Globalization Supply Chain Pharmaceuticals McKinsey 10

Harvard Business Review

APRIL 24, 2017

In addition to homing in on targeted research and development efforts, governments have a unique obligation to work with the international community, such as the World Health Organization, to ensure a common response framework is in place, particularly in fragile states, whose health systems are underdeveloped. Science/technology community.

Project 10

Project Disaggregation Globalization Comparison 10

Harvard Business Review

MARCH 27, 2018

political system, including the 2016 U.S. Apple and Google, for example, each control a popular mobile phone operating system platform (and key apps on that platform), Amazon controls the largest online merchant platform, and Facebook controls the largest social network platform. Nor is it likely to be the last. presidential election.”

Company 13

Company Advertising Incentives Engineering 13

Harvard Business Review

SEPTEMBER 5, 2016

Cigna is the first insurance company to get pharmaceutical companies to agree to value pricing based on results for certain cholesterol-lowering drugs. And providers want the flexibility to deliver outcomes in the best, most innovative, and most efficient way possible without being micromanaged by the customer. ” Health care.

Incentives 8

Incentives Health Care Education Insurance 8

Harvard Business Review

FEBRUARY 4, 2013

How easy is it to change a flawed economic or governance system, such as our current 1.5-planets-and-counting We'd see more corporate social responsibility, socially responsible investing and sustainability reporting, but overall the outcome would be little more than a set of patches on the existing, dysfunctional system.

EPS 9

EPS Innovation CEO Pharmaceuticals 9

Harvard Business Review

APRIL 16, 2012

As long as the CFO can stipulate that the company does not intend to repatriate the cash, it avoids the incremental tax that will be levied due to the territorial system of U.S. high technology or pharmaceutical) that are investing in projects with uncertain long-range payoffs. Facilitate Acquisitions.

Company 14

Company Cost of Capital Finance Long-term 14

Harvard Business Review

OCTOBER 26, 2011

Between 2006 and 2008, more than $1 billion venture-capital dollars were channeled into startups focused on solar, wind and biofuel technologies. In the last year, however, early-stage investments in clean energy production technologies have fallen substantially (see the table at the end of this piece for more detail).

Energy 12

Energy Finance IPO Biotechnology 12

Harvard Business Review

JUNE 14, 2017

How the most innovative providers are creating value. Some firms have managed it, in healthcare and in other arenas — think of QuintilesIMS as a source of pharmaceutical sales data, Nielsen as the authority on TV viewer habits, and the U.S. Insight Center. The Leading Edge of Health Care. Sponsored by Optum. demographics.

Health Care 10

Health Care Levitt Competitive Advantage Pharmaceuticals 10

Harvard Business Review

APRIL 13, 2015

Predictions like this are based on an understanding of dynamics in something business school professors call “value networks” — the system of businesses and service providers that work together to create value for customers. The development of these technologies is setting the stage for machines to think. billion.

Software 8

Software Trends Mass Marketing Marketing 8

Harvard Business Review

SEPTEMBER 5, 2013

So large-scale re-engineering programs, productivity drives, and changes to the incentive system are unlikely to work: they can easily be resisted, ignored or gamed. Marissa Mayer, Yahoo''s CEO, ended the company''s work-from-home policy to foster a more collaborative, innovative environment. Build smart support systems.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

SEPTEMBER 20, 2013

Content Innovation. Very importantly, they were able to avoid costly technology and implementation programs that would have surely fell short of usage and revenue expectations. They assume that if they collect the data, and house it in their systems, it must be their data. In some cases, they’re right.

Execution 8

Execution Metrics Content Christensen 8

Harvard Business Review

SEPTEMBER 7, 2015

Strategists learn to manage and steer complex systems—without the costly risk of bankruptcy. Exogenous shocks (new technologies, economic-political events) were incorporated as well to train players to stay agile and flexible. The game play included collaborative interactions like agreeing on M&A/JV efforts.

Seminar 8

Seminar Learning Curve Strategy Comparison 8

Harvard Business Review

SEPTEMBER 4, 2015

Innovation is widely regarded as important to long-term business performance. We’ve found that CEOs of big pharmaceutical companies, for example, are more likely to have a background as company lawyers, salespeople, or finance managers, than one in medicine or pharmaceutical R&D. Overall, it is a messy picture.

CEO 8

CEO Innovation Pharmaceuticals Merchandising 8

Harvard Business Review

SEPTEMBER 20, 2011

A vast ideological gap on macro-economic policy divides Washington and much of the nation, but there is almost universal agreement on one solution: innovation. Innovation is now perceived as a panacea for job creation, income generation, economic growth, dollar strength, and the revival of the U.S. as global hegemon.

Innovation 13

Innovation Supply Chain Offshoring Policies 13

Harvard Business Review

NOVEMBER 12, 2018

With a $1 million price tag, limited data on efficacy and just 700 potential patients in Europe, health systems were unwilling to pay for treatment. Our research on major innovations finds that when disruption occurs, technologies don’t replace technologies; systems replace systems.

Business Model 12

Business Model Insurance Cost Bond 12

Harvard Business Review

NOVEMBER 29, 2016

The emergence of big data, as well as advancements in data science approaches and technology, is providing pharmaceutical companies with an opportunity to gain novel insights that can enhance and accelerate drug development. Innovating for Value in Health Care. Insight Center. Sponsored by Medtronic.

Pharmaceuticals 8

Pharmaceuticals Incubator Health Care Biotechnology 8